发明名称 NEW SPLICE MUTANT OF ATG-1120 (AIF-1-DELTA), AIF-1/RC-9
摘要 PROBLEM TO BE SOLVED: To obtain a new nucleotide having a high idneticalness to a sequence encoding an ATG-1120 (AIF-1-δ) polypeptide having a specific amino acid sequence and useful for the treatment, diagnosis, etc., of arteriosclerosis, hypertension, cancer, an autoimmune disease, etc. SOLUTION: This new splice mutant is a new isolated nucleotide sequence having at least 80% identicalness over the whole length of a nucleotide encoding an ATG-1120 (AIF-1-δ) polypeptide having an amino acid sequence expressed by the formula, or a complemental nucleotide sequence to the above nucleotide sequence, and useful for the treatment, diagnosis, etc., of arteriosclerosis, a CHF, a recurrent stenosis, myocardial infarct, hypertension, a cerebroarterial phenomenon, dyshematopoiesia, an ARDS, cancer (especially leukemia), an autoimmune disease, an inflammatory disease, renal glomerulopathy, etc. The polynucleotide is obtained by screening a suitable library by using a radio- labelled probe, etc., under a stringent condition.
申请公布号 JPH11185(A) 申请公布日期 1999.01.06
申请号 JP19980139681 申请日期 1998.05.21
申请人 SMITHKLINE BEECHAM CORP 发明人 DOUGLAS STEPHEN A
分类号 G01N33/566;A61K31/70;A61K38/00;A61K39/00;A61K39/395;A61K48/00;A61P7/00;A61P9/00;A61P9/10;A61P13/02;A61P15/00;A61P29/00;A61P35/02;A61P37/00;C07K14/47;C07K16/18;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12N15/12;C12P21/02;C12P21/08;C12Q1/02 主分类号 G01N33/566
代理机构 代理人
主权项
地址